Bio-Quant, Inc., a contract research organization, provides in-vitro and in-vivo contract drug discovery and pre-clinical development services in the United States. It conducts non GLP drug discovery research services primarily in oncology, inflammation, immunology, and diabetes. Its services include in vitro and in vivo pharmacology, pharmacokinetic, and toxicology services, as well as vivarium housing, antibody production, and in vitro assays services. Bio-Quant also offers various biomarkers in mouse, rats, rabbit, pig, NHPs, and human species.

Company was acquired by BioTox Sciences